Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Liabilities and Shareholders Equity (2016 - 2026)

Updated

Avenue Therapeutics' Liabilities and Shareholders Equity came in at $1.98 million for Q2 2026, down 52.5% from $4.16 million a year earlier and down 19.9% from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

At the end of FY2025, Avenue Therapeutics' Liabilities and Shareholders Equity was $2.93 million, up 9.7% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $2.67 million in FY2024 (+44.4%), $1.85 million in FY2023 (-73.0%), $6.85 million in FY2022 (+72.9%) and $3.96 million in FY2021 (+22.0%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q4 2023.
  • Year-over-year, Liabilities and Shareholders Equity increased in five of the last eight quarters, with growth averaging 53.4%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2024 (growth of 422.9%), and the weakest in Q3 2021 (a decline of 84.2%).
  • Business Quant data shows ATXI's Liabilities and Shareholders Equity at $2.47 million (Q1 2026), $2.93 million (Q4 2025) and $3.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 197.43 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 135.12 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 201.13 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - 1.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.98 Mn
Mar 31, 2026 2.47 Mn
Dec 31, 2025 2.93 Mn
Sep 30, 2025 3.73 Mn
Jun 30, 2025 4.16 Mn
Mar 31, 2025 3.59 Mn
Dec 31, 2024 2.67 Mn
Sep 30, 2024 2.63 Mn
Jun 30, 2024 4.99 Mn
Mar 31, 2024 3.31 Mn
Dec 31, 2023 1.85 Mn
Sep 30, 2023 502,000.00
Jun 30, 2023 1.67 Mn
Mar 31, 2023 8.45 Mn
Dec 31, 2022 6.85 Mn
Sep 30, 2022 575,000.00
Jun 30, 2022 1.01 Mn
Mar 31, 2022 1.96 Mn
Dec 31, 2021 3.96 Mn
Sep 30, 2021 688,000.00
API Access

Avenue Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ATXI&period=max&api_key=YOUR_API_KEY